The ACT Platform
Chemotherapy is non-selective
- Damages normal cells, creating toxicity
Current targeted therapy (e.g. Gleevec, Iressa) is less toxic but has narrow spectrum
ACT appears to be a fundamental advance
- Selectively kills cancer cells in animal models
- Retains broad spectrum in animal models